Bibliographic information
GuidelineWHO policy on collaborative TB/HIV activities : guidelines for national programmes and other stakeholders
Year of Publication2012
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
TB patients with known positive HIV status and TB patients living in HIV-prevalent settings should receive at least 6 months of a rifampicin-containing treatment regimen. The optimal dosing frequency is daily during the intensive and continuation phases
Recommended in favor
Strong
Certainty of evidence
High
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year2016
InstitutionWHO